United Therapeutics (UTHR) Raw Materials (2010 - 2020)

United Therapeutics has disclosed Raw Materials across 11 years of filings, most recently posting $20.1 million for Q1 2020.

• In Q1 2020, Raw Materials fell 9.87% year-over-year to $20.1 million; the TTM figure through Mar 2020 stood at $20.1 million (down 9.87% YoY), while the FY2019 annual figure was $21.1 million, down 13.17% from the prior year.
• Raw Materials came in at $20.1 million for Q1 2020 at United Therapeutics, down from $21.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $29.1 million in Q2 2017 to a low of $19.3 million in Q3 2019.
• Average Raw Materials over 5 years is $24.4 million, with a median of $24.8 million recorded in 2016.
• Year-over-year, Raw Materials grew 17.34% in 2017 and fell 25.77% in 2019.
• Over 5 years, Raw Materials stood at $25.4 million in 2016, then increased by 9.84% to $27.9 million in 2017, then fell by 12.9% to $24.3 million in 2018, then slipped by 13.17% to $21.1 million in 2019, then retreated by 4.74% to $20.1 million in 2020.
• Per Business Quant data, the three most recent Raw Materials figures were $20.1 million in Q1 2020, $21.1 million in Q4 2019, and $19.3 million in Q3 2019.